Sahlgrenska Osteoporosis Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Department of Geriatric Medicine, Sahlgrenska University Hospital, Mölndal, Sweden.
Sahlgrenska Osteoporosis Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Närhälsan Norrmalm, Health Centre, Sweden.
Bone. 2024 Oct;187:117204. doi: 10.1016/j.bone.2024.117204. Epub 2024 Jul 15.
Older women diagnosed with osteoporosis and referred to their general practitioners (GPs) exhibited significantly higher osteoporosis treatment rates and a reduced fracture risk compared to non-osteoporotic women who were not referred to their GPs.
The objective of this study was to investigate treatment rates and fracture outcomes in older women, from a population-based study, 1) diagnosed with osteoporosis, with subsequent referral to their general practitioner (GP), 2) women without osteoporosis, without referral to their GP.
In total, 3028 women, 75-80 years old were included in the SUPERB cohort. At inclusion, 443 women were diagnosed with osteoporosis (bone mineral density (BMD) T-score ≤ -2.5) at the lumbar spine or hip, did not have current or recent osteoporosis treatment, and were referred to their GP for evaluation (referral group). The remaining 2585 women without osteoporosis composed the control group. Sensitivity analysis was performed on subsets of the original groups. Adjusted Cox regression (hazard ratios (HR) and 95 % confidence intervals (CI)) analyses were performed to investigate the risk of incident fractures and the incidence of osteoporosis treatment.
Cox regression models, adjusted for age, sex, body mass index (BMI), smoking, alcohol, glucocorticoid use, previous fracture, parent hip fracture, secondary osteoporosis, rheumatoid arthritis, and BMD at the femoral neck, revealed that the risk of major osteoporotic fracture was significantly lower (HR = 0.81, 95 % CI [0.67-0.99]) in the referral group than in the controls. Similarly, the risk of hip fracture (HR = 0.69, [0.48-0.98]) and any fracture (HR = 0.84, [0.70-1.00]) were lower in the referral group. During follow-up, there was a 5-fold increase (HR = 5.00, [4.39-5.74]) in the prescription of osteoporosis medication in the referral group compared to the control group.
Screening older women for osteoporosis and referring those with osteoporosis diagnosis was associated with substantially increased treatment rates and reduced risk of any fracture, MOF, and hip fracture, compared to non-osteoporotic women.
本研究旨在通过一项基于人群的研究,调查 1) 被诊断为骨质疏松症且随后被转介给全科医生 (GP) 的老年女性,以及 2) 未被转介给 GP 的无骨质疏松症女性的治疗率和骨折结局。
在 SUPERB 队列中,共纳入了 3028 名 75-80 岁的女性。在纳入时,443 名女性被诊断为骨质疏松症(腰椎或髋部骨密度 (BMD) T 评分≤-2.5),没有当前或近期的骨质疏松症治疗,且被转介给 GP 进行评估(转诊组)。其余 2585 名无骨质疏松症的女性为对照组。对原始组的子集进行了敏感性分析。使用调整后的 Cox 回归(风险比 (HR) 和 95%置信区间 (CI)) 分析来研究骨折风险和骨质疏松症治疗的发生率。
调整年龄、性别、体重指数 (BMI)、吸烟、饮酒、糖皮质激素使用、既往骨折、父母髋部骨折、继发性骨质疏松症、类风湿关节炎和股骨颈 BMD 后,Cox 回归模型显示,主要骨质疏松性骨折的风险在转诊组显著低于对照组(HR=0.81,95%CI [0.67-0.99])。同样,转诊组髋部骨折(HR=0.69,[0.48-0.98])和任何骨折(HR=0.84,[0.70-1.00])的风险也较低。在随访期间,转诊组开处骨质疏松症药物的处方增加了 5 倍(HR=5.00,[4.39-5.74])。
与非骨质疏松症女性相比,对老年女性进行骨质疏松症筛查并将骨质疏松症诊断转介给 GP,与治疗率显著增加和任何骨折、MOF 和髋部骨折风险降低相关。